Goodwin’s Capital Markets team advised The Chemours Company (“Chemours”) on its private offering of $600,000,000 in aggregate principal amount of 8.000% senior unsecured notes due 2033 (the “Notes”) that was exempt from the registration requirements of the Securities Act of 1933, as amended. The Notes are Chemours’ senior unsecured obligations and are guaranteed by certain of its subsidiaries. The net proceeds of the offering are expected to be used to redeem all of the Company’s outstanding euro-denominated 4.000% Senior Notes due 2026, which is expected to be €440,810,000, plus accrued and unpaid interest to, but excluding, the date of redemption, and the remainder of the net proceeds for general corporate purposes.
The Chemours Company is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas.
The Goodwin team was led by David Lynn, Jim Barri, and Jon Burr and included Jacqueline Kaufman, Anna Dodson, Elizabeth Kates, Jacob Frank, Dan Karelitz, Garrett Gaughan, Jonathan Hecht, Patrick Menasco, Hasan Cetin, John Servidio, Barry Bazian, Brynn Peltz, Nathan Brodeur, Kate Minorini, Ettore Santucci, and Sofia Wyman.
For more information on the deal, please read the press release.